The Inform Diagnostics Registry
What is the Inform Diagnostics Registry?
The Inform Diagnostics Patient Registry of Hematopoietic Diseases is a
multi-center, observational outcomes database designed to collect data
on the demographics, presentation, diagnosis, treatment, resource use,
and outcomes of eligible patients who previously have undergone Inform
Diagnostics Life Sciences hematopoietic diagnostics testing.
The Registry is no longer accepting new sites.
Benefits of the Inform Diagnostics Registry
Some of the features and benefits of the Inform Diagnostics Registry include:
No changes to the way the clinician manages his/her patient
WIRB-approved verbal consent model
No quotas/volume requirements to fulfill
Registry data is entered into a user-friendly online portal, accessible 24/7
Subjects enrolled in the registry count toward meeting ACoS Cancer Program
Research accrual requirements
All required registry data is already in your patients’ clinical
Participation guidelines have been separately determined by the Inform
Diagnostics Registry team, pursuant to a protocol which has been approved
by an independent Institutional Review Board (IRB).
How Does the Inform Diagnostics Registry Work?
Detailed data from hematopoietic diagnostic testing completed at Inform
Diagnostics is integrated with patients’ clinical data, including
demographics, diagnostic, prognostic, treatment, and outcome data. This
information is collected and tracked over time in three intervals: enrollment,
one year, and five years/off-study.
Who Is Considered an “Eligible Patient"?
Bone marrow and comprehensive peripheral blood cases are invited for enrollment
into the Inform Diagnostics Registry if the following minimum inclusion
criteria are met:
Participation in the registry is voluntary. All patients who meet the protocol
inclusion/exclusion criteria, and who are seen within a participating
physician practice, are potential candidates for this registry.